Clinical Trials Browser

Rectal Neoplasms × tucatinib × 90 days × Clear all

NCT05672524 2026-05-12

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms